Donkor ES. Stroke in the 21(st) century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018;2018:3238165.
PubMed
PubMed Central
Google Scholar
Labberton AS, Augestad LA, Thommessen B, Barra M. The association of stroke severity with health-related quality of life in survivors of acute cerebrovascular disease and their informal caregivers during the first year post stroke: a survey study. Qual Life Res. 2020. https://doi.org/10.1007/s11136-020-02516-3.
Article
PubMed
PubMed Central
Google Scholar
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–29.
Article
CAS
Google Scholar
Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45(1):315–53.
Article
Google Scholar
de Weerd L, Rutgers WA, Groenier KH, van der Meer K. Perceived wellbeing of patients one year post stroke in general practice–recommendations for quality aftercare. BMC Neurol. 2011;11:42.
Article
Google Scholar
Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Anderson CS. Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989–1990. Stroke. 2002;33(4):1034–40.
Article
Google Scholar
Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021. https://doi.org/10.1177/2396987321989865.
Article
PubMed
PubMed Central
Google Scholar
Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–89.
Article
Google Scholar
Chung JW, Park SH, Kim N, Kim WJ, Park JH, Ko Y, et al. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification and vascular territory of ischemic stroke lesions diagnosed by diffusion-weighted imaging. JAHA. 2014. https://doi.org/10.1161/JAHA.114.001119.
Article
PubMed
PubMed Central
Google Scholar
Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–70.
Article
CAS
Google Scholar
Broderick JP, Adeoye O, Elm J. Evolution of the modified rankin scale and its use in future stroke trials. Stroke. 2017;48(7):2007–12.
Article
Google Scholar
Duncan P, Bode R, Lai S, Perera S. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003;84:950–63.
Article
Google Scholar
Lai SM, Studenski S, Duncan PW, Perera S. Persisting consequences of stroke measured by the Stroke Impact Scale. Stroke. 2002;33(7):1840–4.
Article
Google Scholar
Tsalta-Mladenov M, Georgieva D, Andonova S. Measuring Quality of Life in Stroke Survivors. Russian Neurol J. 2020;25(3):11–6.
Article
Google Scholar
Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. New York: John Wiley & Sons; 2013.
Book
Google Scholar
Tsalta-Mladenov M, Dimitrova V, Georgieva-Hristova D, Andonova S. Study on the risk profile of patients with acute stroke hospitalized in the Second Clinic of Neurology, St Marina University Hospital. Varna Medical Forum. 2019;8(1):73–8.
Article
Google Scholar
Asdaghi N, Wang K, Ciliberti-Vargas MA, Gutierrez CM, Koch S, Gardener H, et al. Predictors of thrombolysis administration in mild stroke: Florida-Puerto Rico collaboration to reduce stroke disparities. Stroke. 2018;49(3):638–45.
Article
Google Scholar
Marto JP, Kauppila LA, Jorge C, Calado S, Viana-Baptista M, Pinho-e-Melo T, et al. Intravenous thrombolysis for acute ischemic stroke after recent myocardial infarction. Stroke. 2019;50(10):2813–8.
Article
Google Scholar
PalomerasSoler E, Casado RV. Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences. Curr Cardiol Rev. 2010;6(3):138–49.
Article
Google Scholar
Sung SF, Chen YW, Tseng MC, Ong CT, Lin HJ. Atrial fibrillation predicts good functional outcome following intravenous tissue plasminogen activator in patients with severe stroke. Clin Neurol Neurosurg. 2013;115(7):892–5.
Article
Google Scholar
Saposnik G, Gladstone D, Raptis R, Zhou L, Hart RG. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke. 2013;44(1):99–104.
Article
Google Scholar
Tu HT, Campbell BC, Christensen S, Desmond PM, De Silva DA, Parsons MW, et al. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation. Int J Stroke. 2015;10(4):534–40.
Article
Google Scholar
Yue R, Li D, Yu J, Li S, Ma Y, Huang S, et al. Atrial fibrillation is associated with poor outcomes in thrombolyzed patients with acute ischemic stroke: a systematic review and meta-analysis. Medicine. 2016. https://doi.org/10.1097/MD.0000000000003054.
Article
PubMed
PubMed Central
Google Scholar
Aндoнoвa C, Гeopгиeвa Д, Кaлeвcкa E, Apгиpoвa B, Димитpoвa B. Oцeнкa нa фaктopитe, пoвлиявaщи изxoдa oт ocтъp иcxeмичeн мoзъчeн инcyлт. Извecтия нa cъюзa нa yчeнитe. 2015;1:28–34.
Google Scholar
Ramos-Lima MJM, Brasileiro IC, Lima TL, Braga-Neto P. Quality of life after stroke: impact of clinical and sociodemographic factors. Clinics (Sao Paulo). 2018;73:e418.
Article
Google Scholar
Guidetti S, Ytterberg C, Ekstam L, Johansson U, Eriksson G. Changes in the impact of stroke between 3 and 12 months post-stroke, assessed with the Stroke Impact Scale. J Rehabil Med. 2014;46(10):963–8.
Article
Google Scholar
Mar J, Masjuan J, Oliva-Moreno J, Gonzalez-Rojas N, Becerra V, Casado MÁ, et al. Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain. Health Qual Life Outcomes. 2015;13(1):36.
Article
Google Scholar
Raina A, Trivedi M, Kate M, Kumar L, EratSreedharan S, Sylaja PN. Temporal sustainability of guideline based door-to-needle times for intravenous thrombolysis for acute ischemic stroke. J Clin Neurosci. 2020;74:164–7.
Article
Google Scholar
Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309(23):2480–8.
Article
CAS
Google Scholar
Harvey J, Al Kasab S, Almallouhi E, Guerrero WR, Debenham E, Turner N, et al. Door to needle time and functional outcome for mild ischemic stroke over telestroke. J Telemed Telecare. 2019;25(6):365–9.
Article
Google Scholar
Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929–35.
Article
CAS
Google Scholar